Chemical Formula: C24H26N2O4

Chemical Formula C24H26N2O4

Found 14 metabolite its formula value is C24H26N2O4

Carvedilol

(+-)-1-(Carbazol-4-yloxy)-3-((2-(O-methoxyphenoxy)ethyl)amino)-2-propanol

Carvedilol is only found in individuals that have used or taken this drug. It is a non-selective beta blocker indicated in the treatment of mild to moderate congestive heart failure (CHF).Carvedilol is a racemic mixture in which nonselective beta-adrenoreceptor blocking activity is present in the S(-) enantiomer and alpha-adrenergic blocking activity is present in both R(+) and S(-) enantiomers at equal potency. Carvedilols beta-adrenergic receptor blocking ability decreases the heart rate, myocardial contractility, and myocardial oxygen demand. Carvedilol also decreases systemic vascular resistance via its alpha adrenergic receptor blocking properties. Carvedilol and its metabolite BM-910228 (a less potent beta blocker, but more potent antioxidant) have been shown to restore the inotropic responsiveness to Ca²⁺ in OH^- free radical-treated myocardium. Carvedilol and its metabolites also prevent OH^- radical-induced decrease in sarcoplasmic reticulum Ca²⁺-ATPase activity. Therefore, carvedilol and its metabolites may be beneficial in chronic heart failure by preventing free radical damage. C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AG - Alpha and beta blocking agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D020011 - Protective Agents > D000975 - Antioxidants D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators Carvedilol (BM 14190) is a non-selective β/α-1 blocker[1]. Carvedilol inhibits lipid peroxidation in a dose-dependent manner with an IC50 of 5 μM. Carvedilol is a multiple action antihypertensive agent with potential use in angina and congestive heart failure[2]. Carvedilol is an autophagy inducer that inhibits the NLRP3 inflammasome[3].

C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AG - Alpha and beta blocking agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D020011 - Protective Agents > D000975 - Antioxidants D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators Carvedilol (BM 14190) is a non-selective β/α-1 blocker[1]. Carvedilol inhibits lipid peroxidation in a dose-dependent manner with an IC50 of 5 μM. Carvedilol is a multiple action antihypertensive agent with potential use in angina and congestive heart failure[2]. Carvedilol is an autophagy inducer that inhibits the NLRP3 inflammasome[3].

(S)-(-)-Carvedilol

C24H26N2O4 (406.18924760000004)

(S)-Carvedilol, the S-enantiomer of Carvedilol, is a non-selective β/α-1 blocker. (S)-Carvedilol exerts protection against the vascular or cardiac toxicity of Doxorubicin (DOX)[1].

(R)-(+)-Carvedilol

C24H26N2O4 (406.18924760000004)

(R)-Carvedilol ((R)-BM 14190), the R-enantiomer of Carvedilol, is a non-selective β/α-1 blocker. (R)-Carvedilol exerts protection against the vascular or cardiac toxicity of Doxorubicin (DOX)[1].

N-[(2S)-3-(4-benzoylphenyl)-1-oxo-1-(prop-2-ynylamino)propan-2-yl]carbamic acid tert-butyl ester

C24H26N2O4 (406.18924760000004)

(6R,7R,8R)-4-[cyclopropyl(oxo)methyl]-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C24H26N2O4 (406.18924760000004)

(6S,7S,8R)-4-[cyclopropyl(oxo)methyl]-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C24H26N2O4 (406.18924760000004)

(6R,7R,8S)-4-[cyclopropyl(oxo)methyl]-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C24H26N2O4 (406.18924760000004)

(6R,7S,8S)-4-[cyclopropyl(oxo)methyl]-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C24H26N2O4 (406.18924760000004)

(6S,7R,8R)-4-[cyclopropyl(oxo)methyl]-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C24H26N2O4 (406.18924760000004)